The	O
role	O
of	O
organ	B-Organ
vascularization	O
and	O
lipoplex	O
-	O
serum	B-Organism_substance
initial	O
contact	O
in	O
intravenous	B-Immaterial_anatomical_entity
murine	O
lipofection	O
.	O

Following	O
intravenous	B-Immaterial_anatomical_entity
administration	O
of	O
cationic	O
lipid	O
-	O
DNA	O
complexes	O
(	O
lipoplexes	O
)	O
into	O
mice	O
,	O
transfection	O
(	O
lipofection	O
)	O
occurs	O
predominantly	O
in	O
the	O
lungs	B-Organ
.	O

This	O
was	O
attributed	O
to	O
high	O
entrapment	O
of	O
lipoplexes	O
in	O
the	O
extended	O
lung	B-Multi-tissue_structure
vascular	I-Multi-tissue_structure
tree	I-Multi-tissue_structure
.	O

To	O
determine	O
whether	O
lipofection	O
in	O
other	O
organs	B-Organ
could	O
be	O
enhanced	O
by	O
increasing	O
the	O
degree	O
of	O
vascularization	O
,	O
we	O
used	O
a	O
transgenic	O
mouse	O
model	O
with	O
tissue	B-Tissue
-	O
specific	O
angiogenesis	O
in	O
liver	B-Organ
.	O

Tail	B-Multi-tissue_structure
vein	I-Multi-tissue_structure
injection	O
of	O
N	O
-	O
(	O
1	O
-	O
(	O
2	O
,	O
3	O
-	O
dioleoyloxy	O
)	O
propyl	O
)	O
-	O
N	O
,	O
N	O
,	O
N	O
-	O
trimethylammonium	O
chloride	O
(	O
DOTAP	O
)	O
/	O
cholesterol	O
lipoplexes	O
resulted	O
in	O
increased	O
lipoplex	O
entrapment	O
in	O
hypervascularized	O
liver	B-Organ
but	O
did	O
not	O
boost	O
luciferase	O
expression	O
,	O
suggesting	O
that	O
lipoplex	O
delivery	O
is	O
not	O
a	O
sufficient	O
condition	O
for	O
efficient	O
organ	B-Organ
lipofection	O
.	O

Because	O
the	O
intravenously	B-Immaterial_anatomical_entity
injected	O
lipoplexes	O
migrated	O
within	O
seconds	O
to	O
lungs	B-Organ
,	O
we	O
checked	O
whether	O
the	O
effects	O
of	O
immediate	O
contact	O
with	O
serum	B-Organism_substance
correlate	O
with	O
lung	B-Organ
lipofection	O
efficiency	O
of	O
different	O
DOTAP	O
-	O
based	O
formulations	O
.	O

Under	O
conditions	O
mimicking	O
the	O
injection	O
environment	O
,	O
the	O
lipoplex	O
-	O
serum	B-Organism_substance
interaction	O
was	O
strongly	O
dependent	O
on	O
helper	O
lipid	O
and	O
ionic	O
strength	O
:	O
lipoplexes	O
prepared	O
in	O
150	O
mM	O
NaCl	O
or	O
lipoplexes	O
with	O
high	O
(	O
greater	O
than	O
33	O
mol	O
%	O
)	O
cholesterol	O
were	O
found	O
to	O
aggregate	O
immediately	O
.	O

This	O
aggregation	O
process	O
was	O
irreversible	O
and	O
was	O
inversely	O
correlated	O
with	O
the	O
percentage	O
of	O
lung	B-Cell
cells	I-Cell
that	O
took	O
up	O
lipoplexes	O
and	O
with	O
the	O
efficiency	O
of	O
lipofection	O
.	O

No	O
other	O
structural	O
changes	O
in	O
serum	B-Organism_substance
were	O
observed	O
for	O
cholesterol	O
-	O
based	O
lipoplexes	O
.	O

Dioleoyl	O
phosphatidylethanolamine	O
-	O
based	O
lipoplexes	O
were	O
found	O
to	O
give	O
low	O
expression	O
,	O
apparently	O
because	O
of	O
an	O
immediate	O
loss	O
of	O
integrity	O
in	O
serum	B-Organism_substance
,	O
without	O
lipid	O
-	O
DNA	O
dissociation	O
.	O

Our	O
study	O
suggests	O
that	O
efficient	O
in	O
vivo	O
lipofection	O
is	O
the	O
result	O
of	O
cross	O
-	O
talk	O
between	O
lipoplex	O
composition	O
,	O
interaction	O
with	O
serum	B-Organism_substance
,	O
hemodynamics	O
,	O
and	O
target	O
tissue	B-Tissue
"	O
susceptibility	O
"	O
to	O
transfection	O
.	O

